REGISTERING FOR MLS NEXT Homegrown & Academy Division? Activate your account, access your club’s iP URL, or reset your password. VIEW INSTRUCTIONS

CONTACT US
NEWS

Kitman labs and National Women’s Soccer League Renew Partnership Across All Clubs and Adds My iP for Club Medical Staff

Renewal extends the league-wide Performance Medicine deployment first announced in 2023, with My iP reporting and visualization now available to medical staff at every NWSL club

SHARE

Share via email

New York, NY and Dublin, Ireland, September 8, 2026 – The National Women’s Soccer League and Kitman Labs, the global leader in performance intelligence, today announced a renewal and expansion of their league-wide partnership. The NWSL has extended its deployment of Kitman Labs’ Performance Medicine Solution across every NWSL club and rolled out My iP, the platform’s reporting and visualization layer, to medical staff at every NWSL club, giving each team’s medical staff their own dashboards and reports built around their role.

The NWSL first deployed Performance Medicine in January 2024, following the original league-wide agreement announced in October 2023. The Solution gives every club a centralized, configurable platform to aggregate and standardize player medical data, and the league has used it to support league-wide medical documentation, evidence-based decision-making and ongoing injury research. The renewal continues that league-wide deployment, with the rollout of My iP marking the next phase of how the league and its clubs work with their medical data.

Building a league-wide medical foundation for the NWSL

The NWSL deployment gives the league a complete, league-wide medical dataset captured in a consistent format across every club, available to support injury research, surveillance and decision-making at both league and club level.

As part of the renewal, every NWSL club will also have access to My iP, the platform’s reporting and visualization layer. Medical staff at each club can build dashboards and reports tailored to their role, surfacing the injury, rehabilitation, screening and availability information most relevant to their day-to-day decisions. The capability extends what has been a league-wide medical data infrastructure into the everyday workflows of practitioners at every NWSL team.

“The NWSL’s continued investment in this partnership reflects how league-level performance technology has matured over the past few years,” said Stephen Smith, Founder and CEO of Kitman Labs. “Across our footprint at the league level, from the NWSL and WSL Football to the Premier League, MLS, the USL Super League and the RFU, we are seeing leagues commit to this technology as core infrastructure. The NWSL renewal is part of that pattern.”

“Two and a half years in, iP has become the backbone of how medical data flows across the league,” said Sarah Gregorius, Vice President of Sporting, NWSL. “The renewal reflects the value our medical teams have drawn from a single, consistent system across every club. With My iP now available to staff at every club, our medical teams have direct control over how they work with that data day to day, in the format that best supports their decisions.”

Kitman Labs has built one of the deepest league-level footprints in elite sport. The company supports more than 2,000 teams, leagues, federations and high performance organisations across 26 countries, including league and governing body partnerships with the NWSL, WSL Football, the Premier League, PGMOL, MLS, MLS Next Pro, MLS Next, the USL Super League and the RFU, among others.

About the National Women’s Soccer League

The National Women’s Soccer League (NWSL) is the premier women’s professional soccer league in the United States, featuring international and national team players from around the world. For more information, visit nwslsoccer.com.

About Kitman Labs

Kitman Labs is the global leader in performance intelligence. Its iP: Intelligence Platform unifies data, workflows, and decision-making across more than 2,000 teams, leagues, federations and high performance organizations in 26 countries, including the NFL, MLS, NWSL, Premier League, WSL Football, and national rugby unions and football federations. iP brings together Performance Medicine, Performance Optimization, Coaching & Development, League Operations, and Core Operations into a single environment, representing the industry’s largest dataset of talent, performance, and medical intelligence across every stage of the athlete lifecycle. Kitman Labs is headquartered in Dublin and Silicon Valley. For more information, visit www.kitmanlabs.com.

Media Contacts

Kitman Labs
The PHA Group
kitmanlabs@thephagroup.com

National Women’s Soccer League
Maddy Schachte
mschachte@nwslsoccer.com

RECENT RELEASES

League One Volleyball Selects Kitman Labs to Power Performance Across Its Professional League

Kitman Labs becomes the performance foundation for LOVB, connecting medical, performance and operational data across every team in one scalable platform

stay updated

Sign up for the monthly round-up of news from Kitman Labs – new Solutions, client announcements, product enhancements, best practices, customer stories and more. Delivered to your inbox.

RELATED

Sports EMR, AMS, or Sports Analytics Software: Why Separate Systems Fall Short

A closer look at the operating system redefining athlete health, performance, and organizational alignment..

From Medical Status to Better Team Health Decisions in My iP

The Medical Overview Dashboard gives teams a ready-to-use view of availability, current injuries and illnesses, recent time-loss, and medical trends...

From Manual Injury Reports to Clearer Injury Review in My iP

The Injury Review Dashboard gives medical teams a standardized way to review injury patterns, incidence and exposure-adjusted rates, injury burden, an..

MLS NEXT Registration Support

Powered by MLS Assist

Returning or new to MLS NEXT? Get step-by-step guidance on activating your Kitman Labs account, logging into your club’s iP: Intelligence Platform URL, resetting your password, and completing registration for the 2026/27 season.

YOU ARE NOW ENTERING THE
AMERICAN
ENGLISH SITE
REDIRECTING TO